专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070264345A1 Transdermal Pharmaceutical Composition 失效
标题翻译：透皮药物组合物
公开(公告)号：US20070264345A1
公开(公告)日：2007-11-15
申请号：US10575145
申请日：2004-10-06
申请人： Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soonse Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
发明人： Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soonse Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
IPC分类号： A61K31/728 , A01N25/04 , A61K9/10 , A61P1/08 , A61P21/02 , A61P21/06 , A61P25/04 , A61P33/00 , A61P35/00 , A61P5/30 , A61P9/10
CPC分类号： A61K31/565 , A61K9/0014 , A61K9/06 , A61K9/1274 , A61K31/57 , A61K47/10 , A61K47/14 , A61K47/36
摘要： The invention relates to a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, iso-propyl myristate and a hyaluronic acid salt or complex for use in the manufacture of transdermal pharmaceutical compositions and healing cosmetics. The invention also relates to transdermal pharmaceutical composition consists of an estrogen and a progestin component as well as a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex. The invention can be applied for transdermal hormone replacement therapy and for other trans-dermal depending on the active principles included.
摘要翻译：本发明涉及含有聚氧乙烯 - 甘油三油酸酯，丙二醇，肉豆蔻酸异丙酯和用于制造透皮药物组合物和愈合化妆品的透明质酸盐或络合物的液晶凝胶。本发明还涉及由雌激素和孕激素组分组成的透皮药物组合物，以及含有聚氧乙烯 - 甘油三油酸酯，丙二醇，肉豆蔻酸异丙酯和透明质酸盐或络合物的液晶凝胶。本发明可以应用于透皮激素替代疗法和其它透皮贴剂，这取决于包括的活性成分。

2. 发明授权

US08743151B1 Snapping message header 有权
标题翻译：捕捉消息头
公开(公告)号：US08743151B1
公开(公告)日：2014-06-03
申请号：US13077890
申请日：2011-03-31
申请人： Richard Fulcher , Attila Bodis , Simon Arscott
发明人： Richard Fulcher , Attila Bodis , Simon Arscott
IPC分类号： G09G5/00
CPC分类号： G06Q10/107 , G06F3/04817
摘要： Methods, systems, and computer-program products for displaying a message header on a client device are provided. An exemplary method for displaying a message header on a client device includes receiving a message on an electronic device and identifying a message header associated with the message. The exemplary method also includes, on a display of the electronic device, displaying a snapped header at a given location and at, least a portion of the message header when any portion of the message is also shown on the display. The exemplary method further includes changing a position of the message on the display while maintaining the display of the snapped header at the given location.
摘要翻译：提供了用于在客户端设备上显示消息头的方法，系统和计算机程序产品。用于在客户端设备上显示消息报头的示例性方法包括在电子设备上接收消息并识别与消息相关联的消息报头。该示例性方法还包括在电子设备的显示器上，当消息的任何部分也被显示在显示器上时，在给定位置处以及消息头部的至少一部分处显示捕捉的报头。该示例性方法还包括在维持在给定位置处的标签头的显示的同时改变显示器上的消息的位置。

3. 发明申请

US20110002993A1 FILM COATED TABLETS CONTAINING DROSPIRENONE AS ACTIVE AGENT AND A METHOD FOR THE PREPARATION THEREOF 审中-公开
标题翻译：含有DROSPIRENONE作为活性剂的薄膜包衣片及其制备方法
公开(公告)号：US20110002993A1
公开(公告)日：2011-01-06
申请号：US12809441
申请日：2008-09-02
申请人： Attila Bodis , Istvan Greiner , Jonathan Mihaly Nagy Kasza
发明人： Attila Bodis , Istvan Greiner , Jonathan Mihaly Nagy Kasza
IPC分类号： A61K9/32 , A61K31/585 , A61P7/10 , A61P15/18
CPC分类号： A61K9/2846 , A61K9/1694 , A61K9/2018 , A61K31/565
摘要： The invention relates to drospirenone containing film-coated tablet with improved resistance against the environmental influences, especially against atmospheric humidity. The invention further relates to a method for the preparation film-coated tablet cores whereby applying the active agent to the core may be accomplished with increased safety.
摘要翻译：本发明涉及屈螺酮含薄膜包衣片，其耐环境影响，特别是抗大气湿度。本发明还涉及一种制备薄膜包衣片芯的方法，其中将活性剂施用于芯可以以更高的安全性来实现。

4. 发明授权

US07728042B2 Transdermal pharmaceutical composition 失效
标题翻译：透皮药物组合物
公开(公告)号：US07728042B2
公开(公告)日：2010-06-01
申请号：US10575145
申请日：2004-10-06
申请人： Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
发明人： Istvan Eros , Ildiko Pannonhalmine Csoka , Erzsebet Soosne Csanyi , Attila Bodis , Erzsebet Lapis , Erzsebet Francsicsne Czinege , Emoke Kissne Csikos , Janos Illes
IPC分类号： A61K31/12
CPC分类号： A61K31/565 , A61K9/0014 , A61K9/06 , A61K9/1274 , A61K31/57 , A61K47/10 , A61K47/14 , A61K47/36
摘要： The invention relates to a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex for use in the manufacture of transdermal pharmaceutical compositions and healing cosmetics. The invention also relates to transdermal pharmaceutical composition consists of an estrogen and a progestin component as well as a liquid crystal gel containing polyoxyethylene-glyceryl-trioleate, propylene-glycol, isopropyl myristate and a hyaluronic acid salt or complex. The invention can be applied for transdermal hormone replacement therapy and for other transdermal depending on the active principles included.
摘要翻译：本发明涉及含有聚氧乙烯 - 甘油三油酸酯，丙二醇，肉豆蔻酸异丙酯和用于制造透皮药物组合物和愈合化妆品的透明质酸盐或络合物的液晶凝胶。本发明还涉及由雌激素和孕激素组分组成的透皮药物组合物，以及含有聚氧乙烯 - 甘油三油酸酯，丙二醇，肉豆蔻酸异丙酯和透明质酸盐或络合物的液晶凝胶。本发明可以应用于透皮激素替代疗法和其它透皮贴剂，这取决于包括的活性成分。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式